Cannagistics, Inc. (CNGT)
- Previous Close
0.0001 - Open
0.0001 - Bid --
- Ask --
- Day's Range
0.0001 - 0.0001 - 52 Week Range
0.0001 - 0.0002 - Volume
11,213 - Avg. Volume
39,392 - Market Cap (intraday)
29,634 - Beta (5Y Monthly) 3.55
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0200 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Cannagistics, Inc. develops, markets, and sells OTC, pharmaceutical, nutraceutical, cosmetic, and health and wellness products. Its product portfolio includes Canagel, an anhydrous hydrogel composition and delivery system; Silverpro, a compression fabric; KidzStrips, a thin film children's toothpaste strip; and ImmuniZin, an immune booster, as well as HydroSoil, a novel fertilizer. The company also provides IcyEase, an ice pack for muscle/joint pain; Slim-D, an appetite-suppressant oral strip; Energy Lighting Strips for oral energy; Micro Voltage Trans Derm C for pain; and CBD 600, a hemp rich oral tincture. It offers products in the areas of pain relief, anti-aging, hygiene, energy, and immune system and biochemical support, as well as skin creams for treatment of disorders and rejuvenations. In addition, the company provides products for veterinary and agricultural use. It offers its products through wholesale and retail establishments, including brick and mortar stores; and ecommerce platforms. The company was formerly known as Precious Investments, Inc. and changed its name to Cannagistics, Inc. in May 2019. Cannagistics, Inc. was incorporated in 2004 and is based in Hauppauge, New York.
www.cannagistics.ioRelated News
Performance Overview: CNGT
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: CNGT
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: CNGT
Valuation Measures
Market Cap
29.63k
Enterprise Value
4.43M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
--
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
-4.25
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-1,356.70%
Return on Equity (ttm)
--
Revenue (ttm)
--
Net Income Avi to Common (ttm)
-17.41M
Diluted EPS (ttm)
-0.0200
Balance Sheet and Cash Flow
Total Cash (mrq)
104
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
-381.72k
Company Insights: CNGT
CNGT does not have Company Insights